Kobo Biotech Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | -- | 40.50 | 77.20 | -- |
| Op profit growth | -- | (12) | 67.50 | -- |
| EBIT growth | -- | (13) | 64 | -- |
| Net profit growth | -- | (7.40) | 53.60 | -- |
| Profitability ratios (%) | ||||
| OPM | 10.60 | 10.60 | 17 | 18 |
| EBIT margin | 8.24 | 8.24 | 13.30 | 14.40 |
| Net profit margin | 3.47 | 3.47 | 5.26 | 6.07 |
| RoCE | 13.10 | 14.20 | 19.60 | -- |
| RoNW | 4.96 | 4.32 | 5.59 | -- |
| RoA | 1.38 | 1.50 | 1.94 | -- |
| Per share ratios () | ||||
| EPS | -- | 6.07 | 6.80 | 4.21 |
| Dividend per share | -- | -- | 1 | 1 |
| Cash EPS | 1.79 | 1.79 | 1.89 | 1.66 |
| Book value per share | 23.60 | 39.10 | 32.80 | 27.30 |
| Valuation ratios | ||||
| P/E | -- | 2.34 | 4.52 | 8.19 |
| P/CEPS | 4.92 | 7.93 | 16.30 | 20.80 |
| P/B | 0.37 | 0.36 | 0.94 | 1.26 |
| EV/EBIDTA | 4.47 | 4.57 | 3.30 | 7.01 |
| Payout (%) | ||||
| Dividend payout | -- | -- | 17.30 | 26.60 |
| Tax payout | (8.10) | (8.10) | (11) | -- |
| Liquidity ratios | ||||
| Debtor days | 178 | 159 | 134 | -- |
| Inventory days | 61.20 | 46.90 | 59.50 | -- |
| Creditor days | (111) | (109) | (112) | -- |
| Leverage ratios | ||||
| Interest coverage | (1.80) | (1.80) | (1.90) | (1.70) |
| Net debt / equity | 3.27 | 1.88 | 1.26 | 2.10 |
| Net debt / op. profit | 4.05 | 3.86 | 1.90 | 4.41 |
| Cost breakup () | ||||
| Material costs | (82) | (82) | (72) | (62) |
| Employee costs | (3) | (3) | (4.50) | (6.40) |
| Other costs | (4.50) | (4.50) | (6.70) | (14) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 |
|---|---|---|---|---|
| Revenue | 103 | 404 | 404 | 287 |
| yoy growth (%) | (74) | -- | 40.50 | 77.20 |
| Raw materials | (92) | (330) | (330) | (206) |
| As % of sales | 89.50 | 81.90 | 81.90 | 71.70 |
| Employee costs | (9) | (12) | (12) | (13) |
| As % of sales | 8.75 | 3.03 | 3.03 | 4.54 |
| Other costs | (2.70) | (18) | (18) | (19) |
| As % of sales | 2.64 | 4.48 | 4.48 | 6.69 |
| Operating profit | (0.90) | 42.90 | 42.90 | 48.90 |
| OPM | (0.90) | 10.60 | 10.60 | 17 |
| Depreciation | (9.60) | (10) | (10) | (11) |
| Interest expense | (24) | (18) | (18) | (21) |
| Other income | 0.25 | 0.37 | 0.37 | 0.23 |
| Profit before tax | (34) | 14.90 | 14.90 | 17.70 |
| Taxes | (0.50) | (1.20) | (1.20) | (2) |
| Tax rate | 1.59 | (8.10) | (8.10) | (11) |
| Minorities and other | -- | 0.33 | 0.33 | (0.60) |
| Adj. profit | (35) | 14 | 14 | 15.10 |
| Exceptional items | -- | -- | -- | -- |
| Net profit | (35) | 14 | 14 | 15.10 |
| yoy growth (%) | (349) | -- | (7.40) | 53.60 |
| NPM | (34) | 3.47 | 3.47 | 5.26 |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
| Profit before tax | 14.90 | 14.90 | 17.70 | 9.84 |
| Depreciation | (10) | (10) | (11) | (6.10) |
| Tax paid | (1.20) | (1.20) | (2) | -- |
| Working capital | 57.70 | 79.80 | (80) | -- |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | 61.40 | 83.50 | (75) | -- |
| Capital expenditure | 23.60 | 17.40 | (17) | -- |
| Free cash flow | 85 | 101 | (92) | -- |
| Equity raised | 55.50 | 103 | 104 | -- |
| Investments | -- | -- | -- | -- |
| Debt financing/disposal | 80.10 | 96.30 | 13.30 | -- |
| Dividends paid | -- | -- | 2.25 | 2.25 |
| Other items | -- | -- | -- | -- |
| Net in cash | 221 | 300 | 27.20 | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
| Equity capital | 22.50 | 22.50 | 22.50 | 22.50 |
| Preference capital | -- | -- | -- | -- |
| Reserves | 30.60 | 65.40 | 51.40 | 38.90 |
| Net worth | 53.10 | 87.90 | 73.90 | 61.40 |
| Minority interest | ||||
| Debt | 179 | 182 | 118 | 131 |
| Deferred tax liabilities (net) | 2.99 | 2.45 | 1.93 | 1.41 |
| Total liabilities | 235 | 272 | 196 | 194 |
| Fixed assets | 106 | 111 | 114 | 110 |
| Intangible assets | ||||
| Investments | -- | -- | -- | -- |
| Deferred tax asset (net) | -- | -- | -- | -- |
| Net working capital | 124 | 145 | 56.80 | 81.60 |
| Inventories | 76 | 59.30 | 44.40 | 49.30 |
| Inventory Days | 68.70 | 53.60 | 56.40 | 111 |
| Sundry debtors | 190 | 205 | 147 | 63.40 |
| Debtor days | 171 | 185 | 187 | 143 |
| Other current assets | 18.50 | 20.50 | 15.40 | 24.70 |
| Sundry creditors | (118) | (100) | (115) | (32) |
| Creditor days | 107 | 90.80 | 146 | 71.30 |
| Other current liabilities | (42) | (39) | (35) | (24) |
| Cash | 5.64 | 16.50 | 25.10 | 2.50 |
| Total assets | 235 | 272 | 196 | 194 |
- Switch to
-
ConsolidatedStandalone
| Report not showing data |
|---|
